![Henrik Lawaetz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Henrik Lawaetz
Directeur Technique/Scientifique/R&D chez
StemCare A/S
Profil
Henrik Lawaetz is currently the Medical Director at StemCare A. Previously, he was the Chief Executive Officer at Center For Clinical & Basic Research from 1995 to 1999, and a Partner & Managing Director at Scandinavian Life Science Invest ApS from 2000 to 2012.
He also held various director positions at Pharmacia AB, Exiqon A, Sophion Bioscience A, Nuevolution AB, Action Pharma A, Independent Pharmaceutica AB, Novo Nordisk Scandinavia AB, Demetech AB, and Biopheresis GmbH.
Additionally, he was the Co-Chairman at Sanos Bioscience A in 2010-2011.
Dr. Lawaetz holds a doctorate degree from The University of Wales and the University of Copenhagen, and an MBA from the Scandinavian International Management Institute.
Postes actifs de Henrik Lawaetz
| Sociétés | Poste | Début |
|---|---|---|
StemCare A/S
 StemCare A/S BiotechnologyHealth Technology Stores stem cells from umbilical cord blood | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Henrik Lawaetz
| Sociétés | Poste | Fin |
|---|---|---|
Scandinavian Life Science Invest ApS
 Scandinavian Life Science Invest ApS Investment ManagersFinance Scandinavian Life Science Invest's investment strategy aims to maximize return on investments. They are active investors in growth firms in the life science sector primarily in the areas of pharmaceutical development, biotechnology and medical technology. They generally take stakes from 10% to 49% in each firm, seeking to influence but not through a controlling interest. They invest in small and mid-sized life science firms primarily in Scandinavia and Europe. They seek long-term capital growth by constructing diversified portfolios through sector, firm size, development stage and financial status. They provide a combination of capital, industrial and financial expertise to their portfolio firms. Scandinavian Life Science Invest prefers to invest in phases after seed capital but before IPO. They look for firms with a strong patent position, clear market potential, proven medical need for the product or technology, expert science and scientific teams and incentives for key employees. The firm's exit strategies include trade sales, IPO and M&A. | Directeur en chef des Investissements | 01/01/2012 |
Sanos Bioscience A/S
 Sanos Bioscience A/S Pharmaceuticals: MajorHealth Technology Develops treatments for osteoporosis and other skeletal wasting diseases | Président | 01/09/2009 |
Center For Clinical & Basic Research
 Center For Clinical & Basic Research Miscellaneous Commercial ServicesCommercial Services Provides radiology services | Directeur Général | 01/01/1999 |
Novo Nordisk Scandinavia AB
 Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products and services | Directeur/Membre du Conseil | - |
Pharmacia AB
 Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Directeur/Membre du Conseil | - |
Formation de Henrik Lawaetz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
78
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Pharmacia AB
Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Exiqon A/S
 Exiqon A/S Miscellaneous Commercial ServicesCommercial Services Engages in the pharmaceutical industry | Commercial Services |
The University of Wales
 The University of Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scandinavian International Management Institute
 Scandinavian International Management Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scandinavian Life Science Invest ApS
Scandinavian Life Science Invest ApS Investment ManagersFinance Scandinavian Life Science Invest's investment strategy aims to maximize return on investments. They are active investors in growth firms in the life science sector primarily in the areas of pharmaceutical development, biotechnology and medical technology. They generally take stakes from 10% to 49% in each firm, seeking to influence but not through a controlling interest. They invest in small and mid-sized life science firms primarily in Scandinavia and Europe. They seek long-term capital growth by constructing diversified portfolios through sector, firm size, development stage and financial status. They provide a combination of capital, industrial and financial expertise to their portfolio firms. Scandinavian Life Science Invest prefers to invest in phases after seed capital but before IPO. They look for firms with a strong patent position, clear market potential, proven medical need for the product or technology, expert science and scientific teams and incentives for key employees. The firm's exit strategies include trade sales, IPO and M&A. | Finance |
Center For Clinical & Basic Research
Center For Clinical & Basic Research Miscellaneous Commercial ServicesCommercial Services Provides radiology services | Commercial Services |
Sophion Bioscience A/S
 Sophion Bioscience A/S Medical SpecialtiesHealth Technology Develops, manufactures and markets instruments and supplies automated patch clamping | Health Technology |
Nuevolution AB
 Nuevolution AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for treatment of oncology and chronic inflammatory diseases | Health Technology |
Sanos Bioscience A/S
Sanos Bioscience A/S Pharmaceuticals: MajorHealth Technology Develops treatments for osteoporosis and other skeletal wasting diseases | Health Technology |
Action Pharma A/S
 Action Pharma A/S BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
StemCare A/S
StemCare A/S BiotechnologyHealth Technology Stores stem cells from umbilical cord blood | Health Technology |
Biopheresis GmbH
 Biopheresis GmbH Miscellaneous Commercial ServicesCommercial Services Provides cancer treatments | Commercial Services |
Independent Pharmaceutica AB
 Independent Pharmaceutica AB Medical DistributorsDistribution Services Provides pharmacological solutions for treatment of nicotine addiction. | Distribution Services |
Wntresearch AB
 Wntresearch AB Pharmaceuticals: OtherHealth Technology Develops novel anti-metastatic therapies based synthetic peptides | Health Technology |
Novo Nordisk Scandinavia AB
Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products and services | Health Technology |
Demetech AB |
